NSE filing, NSE: LUMAXTECH. Summary written from the filing by ALFA Finder's alert engine.
Lumax Auto Technologies Ltd: key numbers
- Share price
- ₹2,014.40
- Market cap
- ₹13,730 Cr
- Revenue (annual)
- ₹4,870 Cr
- Net profit (annual)
- ₹278.9 Cr
- P/E (TTM)
- 37.9×Sector 31.3×
- Promoter holding
- 55.98%+0.00% QoQ
- FII holding
- 8.89%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lumax Auto Technologies Ltd
All →Lumax Auto Technologies Earnings Call Transcript: Key Takeaways
Lumax reports record revenue surpassing ₹1,500 Cr milestone, driven by robust automotive sector recovery.
- Call
- Guides 20% growth
Lumax Auto Technologies Investor Presentation: Key Takeaways
Q2FY27 revenue INR 1,556 Cr (+35% YoY), PAT INR 117 Cr (+50%), EBITDA margin flat at 14.7%. Strategy anchored on a 20% revenue CAGR North Star through FY31e.
- Call
- Guides 20% growth
Lumax Auto Technologies Results Update
Lumax Auto Technologies released investor highlights for Q2 and H1 FY27, showing revenue of Rs 1,556 Crore in Q2 (up 35% YoY). PAT before minority interest rose 50% to Rs 117 Crore.
Lumax Auto Technologies Q2 FY27 Results: Net Profit ₹116.7 Cr, Up 50.4% YoY
Lumax Auto Technologies Ltd reported revenue from operations of ₹1,556 Cr (+34.5% YoY) and net profit of ₹116.7 Cr (+50.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹116.7 Cr · +50.4% YoY
Lumax Auto Technologies Other Announcement
Lumax Auto Technologies Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations for the quarter ended September 30, 2026.
Lumax Auto Technologies Board Meeting Date
Lumax Auto Technologies scheduled a board meeting for October 24, 2026, to approve unaudited financial results for the second quarter and half-year ended September 30, 2026.
Other legal & regulatory announcements
All →Nephrocare Health Services Legal & Regulatory
Nephrocare's Uzbek subsidiary won a court ruling invalidating a ₹14.79 crore tax demand. The tax department must reconsider the audit, and the decision remains appealable.
- Value
- ₹14.79 Cr
Supriya Lifescience Legal & Regulatory
Supriya Lifescience disclosed that its General Manager, Sales & Marketing, was granted bail in an NDPS Act case. The company says the order has no material impact.
Muthoot Finance Legal & Regulatory
Muthoot Finance disclosed a GST Department search and seizure at its Registered Office, conducted October 29-30, 2026. The company states business operations remained unaffected and it is cooperating fully.
Praveg Legal & Regulatory
Praveg received a SEBI penalty order of ₹2 lakh over amalgamation-related non-compliance. The penalty is payable within 45 days.
- Value
- ₹0.02 Cr
Tube Investments of India Legal & Regulatory
Tube Investments received a Punjab Pollution Control Board order imposing ₹39 lakh environmental compensation for partial non-compliance with its Consent to Operate. The company says there is no material impact on its operations or finances.
- Value
- ₹0.39 Cr
Mitsu Chem Plast Legal & Regulatory
Mitsu Chem Plast clarified a late disclosure of its auditor's conversion into an LLP. No auditor change occurred, and the company acknowledged the lapse.